Dr Vincent Xie
Independent consultant and advisor, Hong Kong.
Dr Xie has 20 years of biopharmaceutical experience from senior management positions with local and Chinese companies in Hong Kong and mainland China, as well as advisory roles including adjunct professor at a Guangzhou-based biomedical translational research institute. He has vast experience from, R&D positions at both biotechnology start-ups and publicly listed biopharmaceutical companies such as the Hong Kong and Shenzhen listed Livzon Pharmaceutical Group Inc. as Director of CMC at Livzon MabPharm Inc. and the Nasdaq-listed China Biologic Products Inc. as Director of R&D. Dr Xie led both preclinical and clinical development of monoclonal antibodies, recombinant proteins, plasma derivatives, oxygen-carrying biologics, and DNA therapeutics, conducted technology transfer and collaboration with European partners, interacting closely with the Chinese NMPA and the European EMA preparing registration dossiers. In addition, Dr. Xie is an inventor on 6 granted patents.
Dr. Xie obtained his B.S. in biochemistry from Sun Yat-sen University in Guangzhou, China, and Ph.D. in physiology from New York Medical College, followed by postdoctoral training in oncology at the University of Hong Kong.